1. Home
  2. VALN vs RES Comparison

VALN vs RES Comparison

Compare VALN & RES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • RES
  • Stock Information
  • Founded
  • VALN 2012
  • RES 1984
  • Country
  • VALN France
  • RES United States
  • Employees
  • VALN N/A
  • RES N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • RES Oilfield Services/Equipment
  • Sector
  • VALN Health Care
  • RES Energy
  • Exchange
  • VALN Nasdaq
  • RES Nasdaq
  • Market Cap
  • VALN 989.8M
  • RES 1.0B
  • IPO Year
  • VALN 2021
  • RES N/A
  • Fundamental
  • Price
  • VALN $8.63
  • RES $4.79
  • Analyst Decision
  • VALN Strong Buy
  • RES Hold
  • Analyst Count
  • VALN 4
  • RES 4
  • Target Price
  • VALN $16.00
  • RES $4.69
  • AVG Volume (30 Days)
  • VALN 153.6K
  • RES 1.6M
  • Earning Date
  • VALN 08-12-2025
  • RES 10-23-2025
  • Dividend Yield
  • VALN N/A
  • RES 3.36%
  • EPS Growth
  • VALN N/A
  • RES N/A
  • EPS
  • VALN N/A
  • RES 0.25
  • Revenue
  • VALN $230,566,060.00
  • RES $1,426,699,000.00
  • Revenue This Year
  • VALN $15.55
  • RES $11.80
  • Revenue Next Year
  • VALN $23.93
  • RES $6.13
  • P/E Ratio
  • VALN N/A
  • RES $19.05
  • Revenue Growth
  • VALN 25.47
  • RES N/A
  • 52 Week Low
  • VALN $3.62
  • RES $4.10
  • 52 Week High
  • VALN $12.25
  • RES $7.22
  • Technical
  • Relative Strength Index (RSI)
  • VALN 46.03
  • RES 56.47
  • Support Level
  • VALN $8.71
  • RES $4.63
  • Resistance Level
  • VALN $9.05
  • RES $4.79
  • Average True Range (ATR)
  • VALN 0.46
  • RES 0.14
  • MACD
  • VALN -0.38
  • RES 0.05
  • Stochastic Oscillator
  • VALN 13.63
  • RES 93.94

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About RES RPC Inc.

RPC Inc is an oilfield services company. It provides specialized oilfield services and equipment to independent and oil and gas companies engaged in the exploration, production, and development of oil and gas properties throughout the United States. The company's operating segment includes Technical Services and Support Services. It generates maximum revenue from the Technical Services segment. Technical Services segment nclude RPC's oil and gas services that utilize people and equipment to perform value-added completion, production and maintenance services directly to a customer's well. Support Services segment consists of drill pipe and related tools, pipe handling, pipe inspection and storage services, and oilfield training and consulting services.

Share on Social Networks: